5VM
5AM Venture Management Portfolio holdings
AUM
$260M
1-Year Return
3.76%
This Quarter Return
-22.04%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$323M
AUM Growth
-$142M
(-31%)
Cap. Flow
-$22.6M
Cap. Flow
% of AUM
-7%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Arvinas
ARVN
|
+$15.3M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
+$7.35M |
| 3 |
VIVE
VIVEVE MED INC
VIVE
|
+$10K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Aprea Therapeutics
APRE
$8.97M
| $99.2M | 30.7% |
142,633
| – | – |
|
2
Q32 Bio
QTTB
$23.5M
| $86M | 26.64% |
307,551
| – | – |
|
|
3
Arvinas
ARVN
$568M
| $40.3M | 12.48% |
1,000,000
-378,423
| -27% | -$15.3M |
|
|
4
Crinetics Pharmaceuticals
CRNX
$3.2B
| $27.4M | 8.48% |
1,862,286
-500,000
| -21% | -$7.35M |
|
5
Cabaletta Bio
CABA
$168M
| $26.8M | 8.29% |
3,669,263
| – | – |
|
6
scPharmaceuticals
SCPH
$302M
| $24.1M | 7.45% |
3,253,440
| – | – |
|
7
IDEAYA Biosciences
IDYA
$2.16B
| $14.3M | 4.42% |
3,463,066
| – | – |
|
8
Cidara Therapeutics
CDTX
$1.66B
| $4.98M | 1.54% |
100,326
| – | – |
|
|
VIVE
9
DELISTED
VIVEVE MED INC
VIVE
| – | – |
-808
| Closed | -$10K |
|